News
-
-
PRESS RELEASE
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
Zomedica Corp. reports 68% year-over-year growth in diagnostic revenues, driven by TRUFORMA and VETGuardian products. The company sees significant progress and strong financial results for the second quarter of 2024 -
-
PRESS RELEASE
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
Zomedica Corp. partners with SIRE Veterinario, S.A. to launch products in Costa Rica, expanding their international sales reach. Collaboration aims to provide cutting-edge veterinary solutions in the region -
-
PRESS RELEASE
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals -
-
-
-
PRESS RELEASE
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
Zomedica partners with Leader Healthcare Group to distribute products in the Gulf Cooperation Council Countries, MENA, and India, expanding their global reach in veterinary health